Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | AbbVie Inc. | Stewart Jeffrey Ryan
(EVP, CHIEF COMMERCIAL OFFICER) |
S | Common Stock, $0.01 par value | D | 58949 | $178.69 - $179.03 | $10,539,506 |
| 2024-03-18 | AbbVie Inc. | Stewart Jeffrey Ryan
(EVP, CHIEF COMMERCIAL OFFICER) |
M | Common Stock, $0.01 par value | A | 26110 | $61.36 - $61.36 | $1,602,109 |
| 2024-02-23 | AbbVie Inc. | Reents Scott T
(EVP, CHIEF FINANCIAL OFFICER) |
S | Common Stock, $0.01 par value | D | 14140 | $177.44 - $177.44 | $2,509,001 |
| 2024-02-23 | AbbVie Inc. | Reents Scott T
(EVP, CHIEF FINANCIAL OFFICER) |
M | Common Stock, $0.01 par value | A | 14140 | $61.36 - $61.36 | $867,630 |
| 2024-02-28 | AbbVie Inc. | Reents Scott T
(EVP, CHIEF FINANCIAL OFFICER) |
F | Common Stock, $0.01 par value | D | 11634 | $178.99 - $178.99 | $2,082,369 |
| 2024-02-29 | AbbVie Inc. | Buckbee Kevin K
(SVP, CONTROLLER) |
S | Common Stock, $0.01 par value | D | 5144 | $176.65 - $176.65 | $908,687 |
| 2024-02-28 | AbbVie Inc. | Buckbee Kevin K
(SVP, CONTROLLER) |
F | Common Stock, $0.01 par value | D | 5339 | $178.99 - $178.99 | $955,627 |
| 2024-02-29 | AbbVie Inc. | Michael Robert A.
(PRES & CHIEF OPERATING OFFICER) |
S | Common Stock, $0.01 par value | D | 68879 | $176.44 - $176.46 | $12,153,956 |
| 2024-02-29 | AbbVie Inc. | Michael Robert A.
(PRES & CHIEF OPERATING OFFICER) |
M | Common Stock, $0.01 par value | A | 21560 | $54.86 - $61.36 | $1,257,011 |
| 2024-02-28 | AbbVie Inc. | Michael Robert A.
(PRES & CHIEF OPERATING OFFICER) |
F | Common Stock, $0.01 par value | D | 37638 | $178.99 - $178.99 | $6,736,825 |
| 2024-02-29 | AbbVie Inc. | Siatis Perry C
(EVP, GC AND SECRETARY) |
S | Common Stock, $0.01 par value | D | 9891 | $177.05 - $178.04 | $1,754,554 |
| 2024-02-28 | AbbVie Inc. | Siatis Perry C
(EVP, GC AND SECRETARY) |
F | Common Stock, $0.01 par value | D | 7885 | $178.99 - $178.99 | $1,411,336 |
| 2024-02-28 | AbbVie Inc. | Stewart Jeffrey Ryan
(EVP, CHIEF COMMERCIAL OFFICER) |
F | Common Stock, $0.01 par value | D | 26121 | $178.99 - $178.99 | $4,675,397 |
| 2024-02-28 | AbbVie Inc. | SALEKI-GERHARDT A...
(EVP, CHIEF OPERATIONS OFFICER) |
F | Common Stock, $0.01 par value | D | 23966 | $178.99 - $178.99 | $4,289,674 |
| 2024-02-28 | AbbVie Inc. | RICHMOND TIMOTHY J.
(EVP, CHIEF HR OFFICER) |
F | Common stock, $0.01 par value | D | 23847 | $178.99 - $178.99 | $4,268,374 |
| 2024-02-28 | AbbVie Inc. | Hudson Thomas J
(SVP, CSO, GLOBAL RESEARCH) |
F | Common Stock, $0.01 par value | D | 20634 | $178.99 - $178.99 | $3,693,279 |
| 2024-02-28 | AbbVie Inc. | Thakkar Roopal
(SVP, CMO, GLOBAL THERAPEUTICS) |
F | Common Stock, $0.01 par value | D | 4914 | $178.99 - $178.99 | $879,556 |
| 2024-02-28 | AbbVie Inc. | Donoghoe Nicholas
(EVP, CHIEF BUS/STRAT OFFICER) |
F | Common Stock, $0.01 par value | D | 16771 | $178.99 - $178.99 | $3,001,841 |
| 2024-02-28 | AbbVie Inc. | GONZALEZ RICHARD A
(CHAIRMAN OF THE BOARD AND CEO) |
S | Common Stock, $0.01 par value | D | 138616 | $177.27 - $177.27 | $24,572,458 |
| 2024-02-28 | AbbVie Inc. | GONZALEZ RICHARD A
(CHAIRMAN OF THE BOARD AND CEO) |
F | Common Stock, $0.01 par value | D | 110249 | $178.99 - $178.99 | $19,733,468 |
| 2024-02-15 | AbbVie Inc. | Donoghoe Nicholas
(EVP, CHIEF BUS/STRAT OFFICER) |
A | Common Stock, $0.01 par value | A | 37853 | $0.00 - $0.00 | $0 |
| 2024-02-15 | AbbVie Inc. | Buckbee Kevin K
(SVP, CONTROLLER) |
A | Common Stock, $0.01 par value | A | 12048 | $0.00 - $0.00 | $0 |
| 2024-02-15 | AbbVie Inc. | Thakkar Roopal
(SVP, CMO, GLOBAL THERAPEUTICS) |
A | Common Stock, $0.01 par value | A | 17796 | $0.00 - $0.00 | $0 |
| 2024-02-15 | AbbVie Inc. | Siatis Perry C
(EVP, GC AND SECRETARY) |
A | Common Stock, $0.01 par value | A | 17796 | $0.00 - $0.00 | $0 |
| 2023-12-26 | AbbVie Inc. | Donoghoe Nicholas
(EVP, CHIEF BUS/STRAT OFFICER) |
S | Common Stock, $0.01 par value | D | 2912 | $154.72 - $154.72 | $450,544 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |